NCT00141258View on ClinicalTrials.gov

Pregabalin Epilepsy Add-On Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

August 31, 2006

Conditions
Partial Seizures
Interventions
DRUG

pregabalin

Trial Locations (5)

Unknown

Pfizer Investigational Site, Daegu

Pfizer Investigational Site, Daejeon

Pfizer Investigational Site, Gwangju

Pfizer Investigational Site, Incheon

Pfizer Investigational Site, Seoul

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00141258 - Pregabalin Epilepsy Add-On Trial | Biotech Hunter | Biotech Hunter